Dain Wahl
Internal Medicine · Cincinnati, OHNPI 1750336897
Payments from drug & device makers
Across 388 payments — averaging $12.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$613
- Novo Nordisk$563
- Gilead$258
- Antares Pharma, Inc.$223
- AstraZeneca$179
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,945100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 198 | $2,071 |
| Lilly USA, LLC | 46 | $613 |
| Novo Nordisk | 42 | $563 |
| Gilead | 16 | $258 |
| Antares Pharma, Inc. | 11 | $223 |
| AstraZeneca | 12 | $179 |
| Otsuka America Pharmaceutical, Inc. | 10 | $161 |
| Axsome Therapeutics, Inc. | 6 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $100 |
| Amgen | 6 | $88 |
| Abbott | 5 | $83 |
| Astellas Pharma US Inc | 4 | $77 |
| Pfizer | 4 | $72 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $60 |
| Hologic Sales And Service, LLC | 3 | $53 |
| Viiv Healthcare Company | 3 | $45 |
| Biogen | 2 | $34 |
| Halozyme Inc | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
How this compares
$4,958 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $46,316 |
| VraylarCariprazine Hcl | 21 | $31,544 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $19,389 |
| EliquisApixaban | 16 | $18,470 |
| Repatha SureclickEvolocumab | 19 | $13,925 |
| Emgality PenGalcanezumab-Gnlm | 12 | $8,059 |
| Oxycodone Hcl | 242 | $5,916 |
| Gabapentin | 191 | $3,493 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 138 | $3,360 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $3,178 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $2,694 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 135 | $2,337 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $1,889 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $1,745 |
| SynthroidLevothyroxine Sodium | 13 | $946 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $563 | $46,31644 claims |
| AbbVieVraylar, Synthroid | $2,071 | $32,49034 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $179 | $22,56739 claims |
| PfizerEliquis | $72 | $18,47016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Cincinnati
- Antoinette PragalosCincinnati$27.8M
- Charles EgerCincinnati$8.7M
- Douglas LoganCincinnati$4.7M
- Leela VrishabhendraCincinnati$3.4M
- Traci TurnerCincinnati$645K
- Vincent MartinCincinnati$398K
- Lisa LarkinCincinnati$276K
- Mark EckmanCincinnati$255K
- Kay JohnsonCincinnati$184K
- Steven FolkerthBeavercreek$9.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.